相关实验视频
Updated: Jul 17, 2025

12:44
The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
25.5K
妇科癌肉类瘤:概述和未来的前景
Laetitia Collet1, Andrea María González López2, Clémence Romeo3
1Institut Jules-Bordet, Breast Cancer Translational Research Laboratory, Bruxelles, Belgium; Institut Jules-Bordet, Department of Medical Oncology, Bruxelles, Belgium; Centre Leon-Berard, Department of Medical Oncology, Lyon, France.
Bulletin du cancer
|September 7, 2023
概括
妇科性癌性瘤 (CS) 是一种罕见的,具有较差生存率的侵袭性癌症. 本综述涵盖了它们的流行病学,病理学,基因组学以及子宫 (UCS) 和卵巢 (OCS) 亚型的当前/未来疗法.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症基因组学 癌症基因组学
- 瘤病理学 瘤病理学
背景情况:
- 妇科癌瘤 (Gynecologic carcinosarcomas,简称CS) 是一种罕见的,具有攻击性的瘤,包括高等级癌和瘤成分.
- 它们占子宫和卵巢恶性瘤的不到5%,其特点是预后不佳,五年总生存率低于30%.
研究的目的:
- 提供关于子宫 (UCS) 和卵巢 (OCS) 癌症的全面审查.
- 讨论流行病学,病理学,基因组景观,当前的治疗策略和这些罕见瘤的未来前景.
主要方法:
- 关于妇科癌瘤的广泛文献综述.
- 对流行病学数据,病理特征和基因组资料的分析.
- 评估当前的治疗方式和新兴的治疗策略.
主要成果:
- 化学疗法是积极的,结果不好,特别是在晚期,化学疗法提供有限的反应率.
- 目前的治疗包括手术和辅助疗法,但有限的临床试验包含阻碍了治疗进步.
- 最近的分子发现为新的治疗方法提供了潜力.
结论:
- 妇科癌类沙尔科马需要进一步的研究,因为它们的攻击性和不良预后.
- 了解基因组环境对于开发有针对性的疗法至关重要.
- 未来的研究和临床试验的纳入对于改善CS患者的治疗结果至关重要.
相关概念视频
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

